bpc-157 human clinical trial musculoskeletal injury Peptide Therapy | Regenerative Medicine What Science ACTUALLY Says About
Description
Janesz notes
The 1000 mcg dose is seen as effective
Convenience drives research into transdermal patches, sublingual formulations, and improved oral delivery systems
A small bubble injected under the skin will be absorbed harmlessly
The peptide demonstrates an interesting property of migrating toward areas of tissue damage throughout the body
